Trademark: ARIXTRA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for ARIXTRA
We do not have any records of a proof of use for ARIXTRA at this moment.
Possible trademark infringements of ARIXTRA
Basic Information about ARIXTRA
- Serial Number
- 76251411
- Filing Date
- 04 May 2001
- Registration Number
- 2823751
- Registration Date
- 16 Mar 2004
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of ARIXTRA on the blockchain with WikiTrademarks.io.
- First use of ARIXTRA anywhere
- ARIXTRA was first used on 01 Feb 2002 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
- First use of ARIXTRA anywhere
- ARIXTRA was first used on 01 Feb 2002 for the primary classification of goods and services, international, 010 (Medical Apparatus)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
Who owns ARIXTRA?
1. MYLAN INSTITUTIONAL INC. ROCKFORD IL
2. MYLAN IRELAND LTD. DUBLIN IL
3. ASPEN GLOBAL INCORPORATED Port Louis IL
4. Glaxo Group Limited Brentford, Middlesex IL
5. Sanofi-Synthelabo 75013 Paris IL
6. Sanofi-Synthelabo 75013 Paris IL
7. Sanofi-Synthelabo 75013 Paris IL
Correspondent
- MYLAN INSTITUTIONAL INC.
- 1718 NORTHROCK COURT
- ROCKFORD, IL 61103
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io